{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T16:35:22Z","timestamp":1791304522554,"version":"4.3.1"},"reference-count":38,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,3]]},"DOI":"10.1097\/bor.0b013e3282f4b1ed","type":"journal-article","created":{"date-parts":[[2009,3,5]],"date-time":"2009-03-05T13:15:15Z","timestamp":1236258915000},"page":"187-191","source":"Crossref","is-referenced-by-count":159,"title":["Hyperuricemia, gout and the metabolic syndrome"],"prefix":"10.1097","volume":"20","author":[{"given":"Juan Garc\u00eda","family":"Puig","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Angeles","family":"Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-12-20210128","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1097\/01.hjh.0000217840.26971.b6","article-title":"The metabolic syndrome: a glance at its history","volume":"24","author":"Sarafidis","year":"2006","journal-title":"J Hypertens"},{"key":"R2-12-20210128","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.2337\/diab.37.12.1595","article-title":"Banting lecture 1988: role of insulin resistance in human disease","volume":"37","author":"Reaven","year":"1988","journal-title":"Diabetes"},{"key":"R3-12-20210128","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1002\/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S","article-title":"Definition, diagnosis and classification of diabetes mellitus and its complications, part 1: diagnosis and classification of diabetes mellitus: provisional report of a WHO consultation","volume":"15","author":"Alberti","year":"1998","journal-title":"Diabet Med"},{"key":"R4-12-20210128","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1046\/j.1464-5491.1999.00059.x","article-title":"European Group for the Study of Insulin Resistance (EGIR). Comment on the provisional report of the WHO consultation (letter)","volume":"16","author":"Balkau","year":"1999","journal-title":"Diabet Med"},{"key":"R5-12-20210128","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1001\/jama.285.19.2486","article-title":"Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III).","volume":"285","year":"2001","journal-title":"JAMA"},{"key":"R6-12-20210128","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.4065\/81.12.1615","article-title":"The metabolic syndrome: concepts and controversy","volume":"81","author":"Johnson","year":"2006","journal-title":"Mayo Clin Proc"},{"key":"R7-12-20210128","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1161\/CIRCULATIONAHA.105.169404","article-title":"Diagnosis and management of the metabolic syndrome: an American Heart Association\/National Heart, Lung, and Blood Institute Scientific Statement","volume":"112","author":"Grundy","year":"2005","journal-title":"Circulation"},{"key":"R8-12-20210128","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/S0140-6736(05)67402-8","article-title":"IDF Epidemiology Task Force Consensus Group. The metabolic syndrome: a new worldwide definition","volume":"366","author":"Alberti","year":"2005","journal-title":"Lancet"},{"key":"R9-12-20210128","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1016\/S0140-6736(07)60958-1","article-title":"The metabolic syndrome in children and adolescents","volume":"369","author":"Alberti","year":"2007","journal-title":"Lancet"},{"key":"R10-12-20210128","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.2337\/diacare.28.7.1769","article-title":"Risk for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome: a summary of the evidence","volume":"28","author":"Ford","year":"2005","journal-title":"Diabetes Care"},{"key":"R11-12-20210128","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1001\/jama.287.3.356","article-title":"Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey","volume":"287","author":"Ford","year":"2002","journal-title":"JAMA"},{"key":"R12-12-20210128","first-page":"364","article-title":"European Group for the Study of Insulin Resistance (EGIR). Frequency of the WHO metabolic syndrome in European cohorts, and an alternative definition of an insulin resistance syndrome","volume":"28","author":"Balkau","year":"2002","journal-title":"Diabetes Metab"},{"key":"R13-12-20210128","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/S1262-3636(07)70067-8","article-title":"The incidence and persistence of the NCEP (National Cholesterol Education Program) metabolic syndrome: the French DESIR study","volume":"29","author":"Balkau","year":"2003","journal-title":"Diabetes Metab"},{"key":"R14-12-20210128","first-page":"230","article-title":"Prevalence of the metabolic syndrome in a Turkish adult population","volume":"17","author":"Ozsahin","year":"2004","journal-title":"Diabetes Nutr Metab"},{"key":"R16-12-20210128","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.2337\/diacare.28.9.2289","article-title":"The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association for the study of Diabetes","volume":"28","author":"Kahn","year":"2005","journal-title":"Diabetes Care"},{"key":"R17-12-20210128","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.2337\/dc06-9911","article-title":"Preventing cardiovascular disease and diabetes: a call to action from the American Diabetes Association and the American Heart Association","volume":"29","author":"Eckel","year":"2006","journal-title":"Diabetes Care"},{"key":"R18-12-20210128","doi-asserted-by":"crossref","first-page":"8","DOI":"10.2337\/dc06-1414","article-title":"The National Cholesterol Education Program \u2013 Adult Treatment Panel III, International Diabetes Federation, and World Health Organization definitions of the metabolic syndrome as predictors of incident cardiovascular disease and diabetes","volume":"30","author":"Lorenzo","year":"2007","journal-title":"Diabetes Care"},{"key":"R19-12-20210128","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1161\/01.STR.0000204354.06965.44","article-title":"Metabolic syndrome and the risk of stroke in middle-aged men","volume":"37","author":"Kurl","year":"2006","journal-title":"Stroke"},{"key":"R20-12-20210128","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S1262-3636(07)70306-3","article-title":"Metabolic syndrome and coronary heart disease risk in a population-based study of middle-aged men from France and Northern Ireland: a nested case-control study from the PRIME cohort","volume":"32","author":"Bataille","year":"2006","journal-title":"Diabetes Metab"},{"key":"R21-12-20210128","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1161\/01.STR.0000206458.58142.f3","article-title":"Influence of metabolic syndrome and general obesity on the risk of ischemic stroke","volume":"37","author":"Chen","year":"2006","journal-title":"Stroke"},{"key":"R22-12-20210128","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1161\/01.STR.0000169945.75911.33","article-title":"Relation between the metabolic syndrome and ischemic stroke or transient ischemic attack: a prospective cohort study in patients with atherosclerotic cardiovascular disease","volume":"36","author":"Koren-Morag","year":"2005","journal-title":"Stroke"},{"key":"R23-12-20210128","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1157\/13085753","article-title":"Serum urate levels and urinary uric acid excretion in subjects with metabolic syndrome","volume":"126","author":"L\u00f3pez-Su\u00e1rez","year":"2006","journal-title":"Med Clin (Barc)"},{"key":"R24-12-20210128","first-page":"1882","article-title":"Serum uric acid levels and risk for vascular diseases in patients with metabolic syndrome","volume":"34","author":"Hjortnaes","year":"2007","journal-title":"J Rheumatol"},{"key":"R25-12-20210128","doi-asserted-by":"crossref","first-page":"2526","DOI":"10.1161\/CIRCULATIONAHA.106.657627","article-title":"Serum concentrations of uric acid and the metabolic syndrome among US children and adolescents","volume":"115","author":"Ford","year":"2007","journal-title":"Circulation"},{"key":"R26-12-20210128","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.amjmed.2006.06.040","article-title":"Prevalence of the metabolic syndrome in individuals with hyperuricemia","volume":"120","author":"Choi","year":"2007","journal-title":"Am J Med"},{"key":"R27-12-20210128","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1002\/art.22466","article-title":"Prevalence of the metabolic syndrome in patients with gout: the Third National Health and Nutrition Examination Survey","volume":"57","author":"Choi","year":"2007","journal-title":"Arthritis Rheum"},{"key":"R28-12-20210128","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/j.amjhyper.2006.02.014","article-title":"Serum uric acid is a determinant of metabolic syndrome in a population-based study","volume":"19","author":"Onat","year":"2006","journal-title":"Am J Hypertens"},{"key":"R29-12-20210128","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1097\/01.hjh.0000239300.48130.07","article-title":"Abnormalities of renal sodium handling in the metabolic syndrome: results of the Olivetti Heart Study","volume":"24","author":"Strazzullo","year":"2006","journal-title":"J Hypertens"},{"key":"R30-12-20210128","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1097\/00004872-199917070-00001","article-title":"Uric acid as a cardiovascular risk factor in arterial hypertension","volume":"17","author":"Puig","year":"1999","journal-title":"J Hypertens"},{"key":"R31-12-20210128","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.numecd.2007.02.011","article-title":"Uric acid and oxidative stress: relative impact on cardiovascular risk","volume":"17","author":"Strazzullo","year":"2007","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"R32-12-20210128","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/ncpneph0019","article-title":"Hypothesis: fructose-induced hyperuricemia as a causal mechanism for the epidemic of the metabolic syndrome","volume":"1","author":"Nakagawa","year":"2005","journal-title":"Nat Clin Pract Nephrol"},{"key":"R33-12-20210128","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/j.amjmed.2005.03.043","article-title":"Serum uric acid and cardiovascular disease: recent developments, where do they leave us?","volume":"118","author":"Baker","year":"2005","journal-title":"Am J Med"},{"key":"R34-12-20210128","doi-asserted-by":"crossref","first-page":"4125","DOI":"10.2174\/138161205774913200","article-title":"Serum uric acid and risk of coronary heart disease","volume":"11","author":"Wannamethee","year":"2005","journal-title":"Curr Pharm Des"},{"key":"R35-12-20210128","doi-asserted-by":"crossref","first-page":"2688","DOI":"10.1002\/art.22014","article-title":"Gout and the risk of acute myocardial infarction","volume":"54","author":"Krishnan","year":"2006","journal-title":"Arthritis Rheum"},{"key":"R36-12-20210128","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1161\/CIRCULATIONAHA.107.703389","article-title":"Independent impact of gout on mortality and risk for coronary heart disease","volume":"116","author":"Choi","year":"2007","journal-title":"Circulation"},{"key":"R37-12-20210128","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.numecd.2005.11.012","article-title":"Endothelial dysfunction and oxidative stress in arterial hypertension","volume":"16","author":"Ferroni","year":"2006","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"R38-12-20210128","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/S1047-2797(99)00037-X","article-title":"Serum uric acid and risk of coronary heart disease: Atherosclerosis Risk in Communities (ARIC) Study","volume":"10","author":"Moriarity","year":"2000","journal-title":"Ann Epidemiol"},{"key":"R39-12-20210128","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1161\/01.STR.0000081983.34771.D2","article-title":"Serum urate as an independent predictor of poor outcome and future vascular events after acute stroke","volume":"34","author":"Weir","year":"2003","journal-title":"Stroke"}],"container-title":["Current Opinion in Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/BOR.0b013e3282f4b1ed","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,13]],"date-time":"2021-05-13T22:56:32Z","timestamp":1620946592000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00002281-200803000-00012"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,3]]},"references-count":38,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1097\/bor.0b013e3282f4b1ed","relation":{},"ISSN":["1040-8711"],"issn-type":[{"value":"1040-8711","type":"print"}],"subject":[],"published":{"date-parts":[[2008,3]]}}}